Author:
Sun Shiwei,Wang Yue,Yao Wei,Yue Peng,Guo Fuyu,Deng Xiaoqian,Zhang Jiandong,Zhang Yangang
Abstract
AbstractWhile it is known that accurate evaluation of overall survival (OS) and disease-specific survival (DSS) for patients with primary adrenal lymphoma (PAL) can affect their prognosis, no stable and effective prediction model exists. This study aimed to develop prediction models to evaluate survival. This study enrolled 5448 patients with adrenal masses from the SEER Program. The influencing factors were selected using the least absolute shrinkage and selection operator regression model (LASSO) and Fine and Gray model (FGM). In addition, nomograms were constructed. Receiver operating characteristic curves and bootstrap self-sampling methods were used to verify the discrimination and consistency of the nomograms. The independent influencing factors for PAL survival were selected by LASSO and FGM, and three models were built: the OS, DSS, and FGS (DSS analysis by FGM) model. The areas under the curve and decision curve analyses indicated that the models were valid. This study developed survival prediction models to predict OS and DSS of patients with PAL. The FGS model was more accurate than the DSS model in the short term. Above all, these models should offer benefits to patients with PAL in terms of the treatment modality choice and survival evaluation.
Publisher
Springer Science and Business Media LLC
Reference35 articles.
1. BiLiGe, W. et al. Predicting factors related with uncured hypertension after retroperitoneal laparoscopic adrenalectomy for unilateral primary aldosteronism. Medicine (Baltimore) 98, e16611. https://doi.org/10.1097/MD.0000000000016611 (2019).
2. Barzon, L., Sonino, N., Fallo, F., Palu, G. & Boscaro, M. Prevalence and natural history of adrenal incidentalomas. Eur. J. Endocrinol. 149, 273–285. https://doi.org/10.1530/eje.0.1490273 (2003).
3. Mansmann, G. et al. The clinically inapparent adrenal mass: Update in diagnosis and management. Endocr. Rev. 25, 309–340. https://doi.org/10.1210/er.2002-0031 (2004).
4. Tischler, A. S., & Gill, A. Pheochromocytoma. In: Lloyd, R. V., Osamura, R.Y., Kloeppel, G., et al. WHO classification of tumours of endocrine organs[M]. 4th ed. Lyon: IARC Press, 183–189 (2017).
5. Mozos, A. et al. Most primary adrenal lymphomas are diffuse large B-cell lymphomas with non-germinal center B-cell phenotype, BCL6 gene rearrangement and poor prognosis. Mod. Pathol. 22, 1210–1217. https://doi.org/10.1038/modpathol.2009.87 (2009).